Johnson & Johnson
Johnson & Johnson succeeds in $30-bn tender offer for Actelion
31 Mar 2017
J&J had clinched the deal in December after raising its offer to $280 per share or $30 billion in cash, which included spinning off Actelion's research and development pipeline
Johnson & Johnson ordered to pay $1.04 bn over faulty hip implants
02 Dec 2016
In lawsuits that were combined in a trial, the federal jury concluding that J&J misled patients and their doctors about the safety of the Pinnacle hip implant
J&J loses third lawsuit over talcum powder link to ovarian cancer
29 Oct 2016
Johnson & Johnson, which is facing over 1,700 lawsuits in state and federal courts over ignoring studies linking its baby powder and Shower-to-Shower talc products to ovarian cancer, has been asked to pay a California woman more than $70 million in damages
